openPR Logo
Press release

Malaria Vaccines Market – Paving the Way for a Malaria-free World | Show Rapid Growth Until 2027 Explore By GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Ltd., Sumaya Biotech and GenVec Inc.

10-09-2019 04:58 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Malaria Vaccines

Malaria Vaccines

The leading research firm Coherent Market Insights published a research report on "Malaria Vaccines Market Size Analysis and Forecast 2026" which serves with all-inclusive, highly-effective, and thoroughly analyzed information in a well-organized manner, based on actual facts, about the Malaria Vaccines Market. The whole information from scratch to the financial and management level of the established industries associated with the Malaria Vaccines Market at the global level is initially acquired by the dedicated team. The gathered data involves the information about the industry’s establishment, market Size, Share, type and the form of products it manufactures, annual sales and revenue generation, the demand of the manufactured product in the market, marketing trends followed by the industry, and a lot more important information.

Nearly half of the global population is at risk of malaria as per stats released by the World Health Organization (WHO). This in turn has led to increased inclination of various healthcare agencies towards addressing this major malady. Global non-profit organizations such as the Melinda Gates Foundation and PATH are working towards developing preventive measures and saving lives of many in the malaria affected regions. Africa accounts for the 90% of malaria cases and hence, this region is the primary target of launching the first malaria vaccine developed by GlaxoSmithKline plc. Mosquirix received EU approval in 2015 and is presently being examined in Africa as a pilot study.

Get Quick access to Report Sample @ https://www.coherentmarketinsights.com/insight/request-sample/37

People in Africa use insecticide-treated mosquito nets and indoor-insecticide spraying for prevention against malarial vectors. Use of insecticide-treated mosquito nets in Africa increased by 80% during 2010-2015 (WHO). Moreover, a number of mosquito repellent products (patches, creams, coils, mats, liquids, etc.) are marketed globally. Besides, non-profit organizations provide cheap and often free treatment facilities to the malarial affected population in Africa. Also, GSK has pledged to sell the vaccines at a much lower cost forgoing its huge profit margins to support the global malaria eradication programs. Furthermore, with more malarial vaccines under research pipeline, the malaria vaccines market is poised for significant growth in near future.

The global malaria vaccines market is expected to be valued at US$ 50.6 million in 2024 and is expected to witness a CAGR of 150.0% during the forecast period (2024 – 2027).

Tremendous potential in the malaria vaccines market

Potential for malaria vaccines is estimated to be huge as a large share of population, 90%-95%, at risk of infection in Africa and South East-Asia. Advent of vaccines for adult population, would be a major breakthrough for the malaria vaccines market. Below are certain alarming statistics that embarks the need for a malaria vaccine:

• Artemisinin resistance has been detected in five countries – Laos, Cambodia, Myanmar, Vietnam and Thailand
• Resistance to P. falciparum parasite against the most available anti-malarial medicines is being reported
• According to the National Vector Borne Disease Control Programme, nearly 95% of the population in India reside in malaria endemic areas
• There were 216 million malaria cases globally in 2016 (WHO)
• Africa is the most affected region with 90% of malaria cases and deaths worldwide (WHO)
• Pregnant women, children below 5 years of age, and tourists from countries with low incidence rate of malaria are identified as the most susceptible target population for malaria

The global malaria vaccines market is expected to experience a huge trajectory growth with the launch of first malarial vaccine in near future.

Increasing accessibility and government support to contribute towards the malaria vaccines market growth

The WHO has established a Global Technical Strategy for Malaria 2016-2030 (GTS) in 2015 with certain defined goals, one of them aimed at eliminating malaria in at least 10 countries. Similarly, the Indian government has established Drug Distribution Centers (DDCs) and Fever Treatment Depots (FTDs) in the rural areas for providing easy access to anti-malarial drugs. Regular monitoring and surveillance by various government programs has helped to reduce malarial cases in India from 2.03 million in 2010 to 1.1 million in 2015. Support from such national and global initiatives will drive malaria vaccines market growth during the forecast period.

Many such non-profit organizations and pharmaceutical companies are conducting research on malaria vaccines. Approximately 31 trials are under progress for malaria vaccine development with a few being blood stage projects. Availability of funds and government support programs will encourage commercialization of product with successful trial results, thus boosting the malaria vaccines market growth trajectory.

Grab Your Report at an Impressive Discount @ https://www.coherentmarketinsights.com/insight/request-discount/37

Reasons to Buy:

• Establish comprehensive understanding of the pipeline activity across this Malaria Vaccines to formulate effective R&D strategies

• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Malaria Vaccines therapeutics

• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Some Important TOC:

• Market Overview
• Global Malaria Vaccines Market Landscape by Player
• Players Profiles
• Global Production, Revenue (Value), Price Trend by Type
• Market Analysis by Application
• Global Malaria Vaccines Production, Consumption, Export, Import by Region (2013-2018)
• Production, Revenue (Value) by Region (2013-2018)
• Malaria Vaccines Manufacturing Analysis
• Industrial Chain, Sourcing Strategy and Downstream Buyers
• Market Dynamics
• Global Malaria Vaccines Market Forecast (2018-2026)
• Research Findings and Conclusion
• Appendix

To Conversation With Our Analysts Click @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/37

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Malaria Vaccines Market – Paving the Way for a Malaria-free World | Show Rapid Growth Until 2027 Explore By GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Ltd., Sumaya Biotech and GenVec Inc. here

News-ID: 1845564 • Views: 222

More Releases from Coherent Market Insights

Ransomware Protection Market Projected to Reach Massive Hike till 2026
The subject matter experts and team of highly-skilled researchers have put in hours of work to collate an authentic research report on the global Ransomware Protection Market. Analysts have studied the various products in the market and offered an unbiased opinion about the factors that likely to drive the market and restrain it. For a detailed study, researchers have used primary and secondary research methodologies. Analysts have also studied the
Network Security Firewall Market Growing With Symsoft, Anam Technologies, Cellus …
In the market research study namely, Global Network Security Firewall Market, 2018 has been considered as the base year and 2018 to 2026 the forecast period to estimate the market size for Keyword. The report gives a comprehensive discussion on the market current flow and patterns, industry development drivers, market share, sales volume, informative diagrams, supply and demand, and numerous different aspects. Featuring global and regional data and over top
Hydrogen Vehicle Market To Grow With Toyota Motor Corporation, Hyundai Motor Com …
The report covers Hydrogen Vehicle Market product demand and supply, revenue, profitability, outcomes, consumer trends, size, major segments and share along with company profiles of the key shareholders performing in the year 2018 to 2026. This report examines and evaluates the global as well as the regional scale of the Hydrogen Vehicle market. This report offers modern trends and opportunities which will help the industry player to grasp market growth.
Chloroform Market Market to Expand Substantially Owing to Technological Innovati …
This Report is a proficient study by Coherent Market Insights the report is an essential reference for those who are looks for detailes information for Chloroform Market. Chloroform Market Reseasch Report is a professional and in-depth study on the current state which focucses on the major drivers and restraints for the key players. Chloroform Industry Reserach Report provides granular analysis of the market Share, Segmentation, revenue forecasts and geographical regions of

All 5 Releases


More Releases for Malaria

Global Malaria Test Kit Market Research Report
This report studies the global Malaria Test Kit market status and forecast, categorizes the global Malaria Test Kit market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report J. Mitra & Co Pvt. Ltd Oscar Alere AccuQuik Precision Biotech CTK Biotech Reliable Pro-detect
Malaria Vaccines – Paving the Way for a Malaria-free World
Recent Study on “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis and Forecast, 2018-2026” Added to Coherent Market Insights Reports Database. Malaria Vaccines Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Malaria Vaccines market research report is a professional
2017 Malaria Diagnostics Market Shows Speedy Growth
September Offer – Flat 20% discount on purchase of this report from 15th to 30th September @ https://www.researchtrades.com/discount/1227159 For more offers post 30th September, kindly contact us. Contact No. : +16269994607 (US)/ +91 7507349866 (IND) Email: sales@researchtrades.com Report Overview: This report studies the global Malaria Diagnostics market, analyzes and researches the Malaria Diagnostics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players
Drugs For Malaria Market: Global Scenario 2022
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten
Malaria Disease Drug Pipeline Analysis
“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug
Malaria Vaccines Market – Global Industry Analysis 2024
Today nearly 40% of the global population is at risk of malaria. According to the World Health Organization (WHO), there were nearly 214 million malaria cases in 2015 and approximately 4,38,000 malarial deaths globally. More than 70% of these deaths occur in children under 5 years of age. The Sub-Saharan Africa carries the highest share of global malaria burden with nearly 89% of malaria cases and 91% of malarial deaths